Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative intramasseteric methylprednisolone for postoperative sequelae after lower third molar surgery
2018-004083-62Phase 4Active
- Sponsor
- Semmelweis University
- Start
- Jul 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain and trismus comparing Intramasseteric methylprednisolone with Placebo intramasseteric injection (2 arms). Primary endpoints: Postoperative swelling, Postoperative trismus and 1 more. Started Jul 2019; status: active.
02
Drugs
methylprednisolone
03
Conditions
postoperative paintrismus
Beyond the preview
Go deeper on 2018-004083-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004083-62.